154 related articles for article (PubMed ID: 16465425)
1. Direct activation of the human major vault protein gene by DNA-damaging agents.
Shimamoto Y; Sumizawa T; Haraguchi M; Gotanda T; Jueng HC; Furukawa T; Sakata R; Akiyama S
Oncol Rep; 2006 Mar; 15(3):645-52. PubMed ID: 16465425
[TBL] [Abstract][Full Text] [Related]
2. p53 Suppresses lung resistance-related protein expression through Y-box binding protein 1 in the MCF-7 breast tumor cell line.
Tian B; Liu J; Liu B; Dong Y; Liu J; Song Y; Sun Z
J Cell Physiol; 2011 Dec; 226(12):3433-41. PubMed ID: 21344396
[TBL] [Abstract][Full Text] [Related]
3. Expression of the major vault protein LRP in human non-small-cell lung cancer cells: activation by short-term exposure to antineoplastic drugs.
Berger W; Elbling L; Micksche M
Int J Cancer; 2000 Oct; 88(2):293-300. PubMed ID: 11004683
[TBL] [Abstract][Full Text] [Related]
4. A very early induction of major vault protein accompanied by increased drug resistance in U-937 cells.
Hu Y; Stephen AG; Cao J; Tanzer LR; Slapak CA; Harrison SD; Devanarayan V; Dantzig AH; Starling JJ; Rome LH; Moore RE
Int J Cancer; 2002 Jan; 97(2):149-56. PubMed ID: 11774257
[TBL] [Abstract][Full Text] [Related]
5. Multidrug resistance and the lung resistance-related protein in human colon carcinoma SW-620 cells.
Kitazono M; Sumizawa T; Takebayashi Y; Chen ZS; Furukawa T; Nagayama S; Tani A; Takao S; Aikou T; Akiyama S
J Natl Cancer Inst; 1999 Oct; 91(19):1647-53. PubMed ID: 10511592
[TBL] [Abstract][Full Text] [Related]
6. YB-1 facilitates basal and 5-fluorouracil-inducible expression of the human major vault protein (MVP) gene.
Stein U; Bergmann S; Scheffer GL; Scheper RJ; Royer HD; Schlag PM; Walther W
Oncogene; 2005 May; 24(22):3606-18. PubMed ID: 15750632
[TBL] [Abstract][Full Text] [Related]
7. Cloning and initial analysis of the human multidrug resistance-related MVP/LRP gene promoter.
Lange C; Walther W; Schwabe H; Stein U
Biochem Biophys Res Commun; 2000 Nov; 278(1):125-33. PubMed ID: 11071864
[TBL] [Abstract][Full Text] [Related]
8. Analysis of MVP and VPARP promoters indicates a role for chromatin remodeling in the regulation of MVP.
Emre N; Raval-Fernandes S; Kickhoefer VA; Rome LH
Biochim Biophys Acta; 2004 Apr; 1678(1):33-46. PubMed ID: 15093136
[TBL] [Abstract][Full Text] [Related]
9. 3'-ethynylcytidine, an RNA polymerase inhibitor, combined with cisplatin exhibits a potent synergistic growth-inhibitory effect via Vaults dysfunction.
Fukushima H; Abe T; Sakamoto K; Tsujimoto H; Mizuarai S; Oie S
BMC Cancer; 2014 Aug; 14():562. PubMed ID: 25087851
[TBL] [Abstract][Full Text] [Related]
10. Hyperosmotic stress up-regulates the expression of major vault protein in SW620 human colon cancer cells.
Ikeda R; Iwashita K; Sumizawa T; Beppu S; Tabata S; Tajitsu Y; Shimamoto Y; Yoshida K; Furukawa T; Che XF; Yamaguchi T; Ushiyama M; Miyawaki A; Takeda Y; Yamamoto M; Zhao HY; Shibayama Y; Yamada K; Akiyama S
Exp Cell Res; 2008 Oct; 314(16):3017-26. PubMed ID: 18671966
[TBL] [Abstract][Full Text] [Related]
11. Disruption of the murine major vault protein (MVP/LRP) gene does not induce hypersensitivity to cytostatics.
Mossink MH; van Zon A; Fränzel-Luiten E; Schoester M; Kickhoefer VA; Scheffer GL; Scheper RJ; Sonneveld P; Wiemer EA
Cancer Res; 2002 Dec; 62(24):7298-304. PubMed ID: 12499273
[TBL] [Abstract][Full Text] [Related]
12. The major vault protein is responsive to and interferes with interferon-gamma-mediated STAT1 signals.
Steiner E; Holzmann K; Pirker C; Elbling L; Micksche M; Sutterlüty H; Berger W
J Cell Sci; 2006 Feb; 119(Pt 3):459-69. PubMed ID: 16418217
[TBL] [Abstract][Full Text] [Related]
13. Expression of the Major Vault Protein (MVP) and Cellular Vault Particles in Fish.
Margiotta AL; Bain LJ; Rice CD
Anat Rec (Hoboken); 2017 Nov; 300(11):1981-1992. PubMed ID: 28710803
[TBL] [Abstract][Full Text] [Related]
14. Efflux kinetics and intracellular distribution of daunorubicin are not affected by major vault protein/lung resistance-related protein (vault) expression.
van Zon A; Mossink MH; Schoester M; Scheper RJ; Sonneveld P; Wiemer EA
Cancer Res; 2004 Jul; 64(14):4887-92. PubMed ID: 15256459
[TBL] [Abstract][Full Text] [Related]
15. Reversal of LRP-associated drug resistance in colon carcinoma SW-620 cells.
Kitazono M; Okumura H; Ikeda R; Sumizawa T; Furukawa T; Nagayama S; Seto K; Aikou T; Akiyama S
Int J Cancer; 2001 Jan; 91(1):126-31. PubMed ID: 11149411
[TBL] [Abstract][Full Text] [Related]
16. Expression of P-gp, MRP, LRP, GST-π and TopoIIα and intrinsic resistance in human lung cancer cell lines.
Wang J; Zhang J; Zhang L; Zhao L; Fan S; Yang Z; Gao F; Kong Y; Xiao GG; Wang Q
Oncol Rep; 2011 Nov; 26(5):1081-9. PubMed ID: 21805041
[TBL] [Abstract][Full Text] [Related]
17. Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex.
Hofland K; Petersen BO; Falck J; Helin K; Jensen PB; Sehested M
Clin Cancer Res; 2000 Apr; 6(4):1488-97. PubMed ID: 10778981
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of apoptosis-related bcl-2 but not bcl-xL or bax proteins in multidrug-resistant MCF-7/Adr human breast cancer cells.
Ogretmen B; Safa AR
Int J Cancer; 1996 Sep; 67(5):608-14. PubMed ID: 8782646
[TBL] [Abstract][Full Text] [Related]
19. SP-transcription factors are involved in basal MVP promoter activity and its stimulation by HDAC inhibitors.
Steiner E; Holzmann K; Pirker C; Elbling L; Micksche M; Berger W
Biochem Biophys Res Commun; 2004 Apr; 317(1):235-43. PubMed ID: 15047174
[TBL] [Abstract][Full Text] [Related]
20. Wilms' tumor 1 enhances Cisplatin-resistance of advanced NSCLC.
Wu C; Wang Y; Xia Y; He S; Wang Z; Chen Y; Wu C; Shu Y; Jiang J
FEBS Lett; 2014 Dec; 588(24):4566-72. PubMed ID: 25447528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
